Tower Research Capital LLC (Trc) Immutep LTD Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Immutep LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 25,104 shares of IMMP stock, worth $42,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,104
Previous 5,617
346.93%
Holding current value
$42,425
Previous $12,000
266.67%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding IMMP
# of Institutions
29Shares Held
1.83MCall Options Held
66.5KPut Options Held
36.3K-
Black Rock Inc. New York, NY839KShares$1.42 Million0.0% of portfolio
-
Meridian Wealth Management, LLC387KShares$653,4380.03% of portfolio
-
Xy Capital LTD Central, K3137KShares$231,0970.07% of portfolio
-
Steward Partners Investment Advisory, LLC61KShares$103,0900.0% of portfolio
-
Jane Street Group, LLC New York, NY51.6KShares$87,1600.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $146M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...